Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Head and Neck Cancer

  Free Subscription


18.02.2019

1 Ann Thorac Surg
4 BMC Cancer
1 Br J Cancer
1 Br J Ophthalmol
2 Cancer
1 Clin Cancer Res
2 Clin Nucl Med
2 Dis Esophagus
5 Head Neck
1 Hum Pathol
1 Int J Cancer
1 J Clin Oncol
2 Laryngoscope
2 Otolaryngol Head Neck Surg
1 PLoS Genet
5 PLoS One
2 Surgery


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Thorac Surg

  1. DENG HY
    Will patients with resectable esophageal cancer be spared esophagectomy?
    Ann Thorac Surg. 2019 Feb 13. pii: S0003-4975(19)30200.
    PubMed     Text format    


    BMC Cancer

  2. LAI K, Matthews S, Wilmott JS, Killingsworth MC, et al
    Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
    BMC Cancer. 2018;18:624.
    PubMed     Text format     Abstract available

  3. YANG L, Liu L, Han B, Han W, et al
    Apatinib treatment for KIT- and KDR-amplified angiosarcoma: a case report.
    BMC Cancer. 2018;18:618.
    PubMed     Text format     Abstract available

  4. CHEN Y, Tian T, Mao MJ, Deng WY, et al
    CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma.
    BMC Cancer. 2018;18:514.
    PubMed     Text format     Abstract available

  5. CHUA KLM, Yeo ELL, Shihabudeen WA, Tan SH, et al
    Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPC.
    BMC Cancer. 2018;18:1095.
    PubMed     Text format     Abstract available


    Br J Cancer

  6. CITRO S, Bellini A, Miccolo C, Ghiani L, et al
    Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for DeltaNp63alpha.
    Br J Cancer. 2019 Feb 15. pii: 10.1038/s41416-019-0394.
    PubMed     Text format     Abstract available


    Br J Ophthalmol

  7. JAYARAJ P, Sen S, Rangarajan S, Ray N, et al
    Immunohistochemical evaluation of stress-responsive protein sestrin2 and its correlation with p53 mutational status in eyelid sebaceous gland carcinoma.
    Br J Ophthalmol. 2018 Feb 24. pii: bjophthalmol-2017-311283.
    PubMed     Text format     Abstract available


    Cancer

  8. LEE NCJ, Kelly JR, An Y, Park HS, et al
    Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma.
    Cancer. 2019 Feb 12. doi: 10.1002/cncr.32001.
    PubMed     Text format     Abstract available

  9. NG SP, Pollard C 3rd, Berends J, Ayoub Z, et al
    Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.
    Cancer. 2019 Feb 12. doi: 10.1002/cncr.31983.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  10. LEE JW, Parameswaran J, Sandoval-Schaefer T, Eoh KJ, et al
    Combined Aurora kinase A (AURKA) and WEE1 inhibition demonstrates synergistic antitumor effect in squamous cell carcinoma of the head and neck.
    Clin Cancer Res. 2019 Feb 12. pii: 1078-0432.CCR-18-0440.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  11. SAKTHIVEL P, Prashanth A, Thakar A, Kumar R, et al
    Juvenile Nasal Angiofibroma on 68Ga-PSMA PET/CT: Opening New Frontiers.
    Clin Nucl Med. 2018 Dec 3. doi: 10.1097/RLU.0000000000002387.
    PubMed     Text format     Abstract available

  12. GARAU LM, Rubello D, Morganti R, Boni G, et al
    Sentinel Lymph Node Biopsy in Small Papillary Thyroid Cancer: A Meta-analysis.
    Clin Nucl Med. 2018 Nov 10. doi: 10.1097/RLU.0000000000002378.
    PubMed     Text format     Abstract available


    Dis Esophagus

  13. KLEVEBRO F, Scandavini CM, Kamiya S, Nilsson M, et al
    Single center consecutive series cohort study of minimally invasive versus open resection for cancer in the esophagus or gastroesophageal junction.
    Dis Esophagus. 2018;31.
    PubMed     Text format     Abstract available

  14. BOSHIER PR, Adam ME, Doran S, Muthuswamy K, et al
    Effects of intraoperative pyloric stretch procedure on outcomes after esophagectomy.
    Dis Esophagus. 2018;31.
    PubMed     Text format     Abstract available


    Head Neck

  15. AVKSHTOL V, Handorf EA, Ridge JA, Leachman BK, et al
    Examining adjuvant radiation dose in head and neck squamous cell carcinoma.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25680.
    PubMed     Text format     Abstract available

  16. SUN W, Chen L, Huang JQ, Li J, et al
    Dynamic changes in chemosensitivity immune predictors in patients with hypopharyngeal cancer treated with induction chemotherapy.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25699.
    PubMed     Text format     Abstract available

  17. COCA-PELAZ A, Halmos GB, Strojan P, de Bree R, et al
    The role of age in treatment-related adverse events in patients with head and neck cancer: A systematic review.
    Head Neck. 2019 Feb 9. doi: 10.1002/hed.25696.
    PubMed     Text format     Abstract available

  18. KIM HK, Park D, Kim HY
    Robotic transoral thyroidectomy: Total thyroidectomy and ipsilateral central neck dissection with da Vinci Xi Surgical System.
    Head Neck. 2019 Feb 13. doi: 10.1002/hed.25661.
    PubMed     Text format     Abstract available

  19. KHARIWALA SS, Rubin N, Stepanov I, Nollen N, et al
    "Cold turkey" or pharmacotherapy: Examination of tobacco cessation methods tried among smokers prior to developing head and neck cancer.
    Head Neck. 2019 Feb 15. doi: 10.1002/hed.25708.
    PubMed     Text format     Abstract available


    Hum Pathol

  20. TERABE T, Uchida F, Nagai H, Omori S, et al
    Expression of autophagy-related markers at the surgical margin of oral squamous cell carcinoma correlates with poor prognosis and tumor recurrence.
    Hum Pathol. 2018;73:156-163.
    PubMed     Text format     Abstract available


    Int J Cancer

  21. KITAHARA CM, Preston DL, Neta G, Little MP, et al
    Occupational radiation exposure and thyroid cancer incidence in a cohort of U.S. radiologic technologists, 1983-2013.
    Int J Cancer. 2018;143:2145-2149.
    PubMed     Text format     Abstract available


    J Clin Oncol

  22. LOWE VJ, Duan F, Subramaniam RM, Sicks JD, et al
    Multicenter Trial of [(18)F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685.
    J Clin Oncol. 2019 Feb 15:JCO1801182. doi: 10.1200/JCO.18.01182.
    PubMed     Text format     Abstract available


    Laryngoscope

  23. NAUNHEIM M, Varvares M, Kirsh E, Holman A, et al
    In response to letter to the editor regarding: "Patient-reported versus physiologic swallowing outcomes in patients with head and neck cancer after chemoradiation".
    Laryngoscope. 2019 Feb 13. doi: 10.1002/lary.27857.
    PubMed     Text format    

  24. AMDUR RJ, Chera BS
    Regarding "patient-reported versus physiologic swallowing outcomes in patients with head and neck cancer after chemoradiation".
    Laryngoscope. 2019 Feb 13. doi: 10.1002/lary.27862.
    PubMed     Text format    


    Otolaryngol Head Neck Surg

  25. TOPF MC, Harshyne L, Tuluc M, Mardekian S, et al
    Loss of CD169(+) Subcapsular Macrophages during Metastatic Spread of Head and Neck Squamous Cell Carcinoma.
    Otolaryngol Head Neck Surg. 2019 Feb 12:194599819829741.
    PubMed     Text format     Abstract available

  26. ELLIS MA, Sterba KR, Brennan EA, Maurer S, et al
    A Systematic Review of Patient-Reported Outcome Measures Assessing Body Image Disturbance in Patients with Head and Neck Cancer.
    Otolaryngol Head Neck Surg. 2019 Feb 12:194599819829018.
    PubMed     Text format     Abstract available


    PLoS Genet

  27. PECCE V, Sponziello M, Damante G, Rosignolo F, et al
    A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency.
    PLoS Genet. 2018;14:e1007678.
    PubMed     Text format     Abstract available


    PLoS One

  28. SHI L, Lai Y, Chen S, Fu L, et al
    Dosimetric superiority of IMRT with jaw tracking technique for whole esophagus and T-shaped field radiotherapy in advanced esophageal cancer.
    PLoS One. 2018;13:e0202628.
    PubMed     Text format     Abstract available

  29. BASHIR K, Sarwar R, Saeed S, Mahjabeen I, et al
    Interaction among susceptibility genotypes of PARP1 SNPs in thyroid carcinoma.
    PLoS One. 2018;13:e0199007.
    PubMed     Text format     Abstract available

  30. LECONTE BA, Szaniszlo P, Fennewald SM, Lou DI, et al
    Differences in the viral genome between HPV-positive cervical and oropharyngeal cancer.
    PLoS One. 2018;13:e0203403.
    PubMed     Text format     Abstract available

  31. ZHAO X, Ren Y, Hu Y, Cui N, et al
    Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials.
    PLoS One. 2018;13:e0202185.
    PubMed     Text format     Abstract available

  32. KIM DS, Kim DW, Heo YJ, Baek JW, et al
    Utility of including BRAF mutation analysis with ultrasonographic and cytological diagnoses in ultrasonography-guided fine-needle aspiration of thyroid nodules.
    PLoS One. 2018;13:e0202687.
    PubMed     Text format     Abstract available


    Surgery

  33. DEFTEREOS I, Kiss N, Isenring E, Carter V, et al
    Letter to the Editors regarding: "Preoperative enteral access is not necessary prior to multimodality treatment of esophageal cancer".
    Surgery. 2019 Feb 8. pii: S0039-6060(18)30837-7. doi: 10.1016/j.surg.2018.
    PubMed     Text format    

  34. VALSANGKAR N, Salfity HVN, Timsina L, Ceppa DP, et al
    Operative time in esophagectomy: Does it affect outcomes?
    Surgery. 2018;164:866-871.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: